FORTIS

Fortis Healthcare Share Price

 

 

Invest in Fortis Healthcare with 3.4X leverage

Invest with MTF

Performance

  • Low
  • ₹845
  • High
  • ₹864
  • 52 Week Low
  • ₹577
  • 52 Week High
  • ₹1,104
  • Open Price₹861
  • Previous Close₹861
  • Volume378,522

Investment Returns

  • Over 1 Month -15.74%
  • Over 3 Month -8.85%
  • Over 6 Month + 12.6%
  • Over 1 Year + 20.33%

Smart Investing Starts Here Start SIP with Fortis Healthcare for Steady Growth!

Invest Now

Fortis Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 63.8
  • PEG Ratio
  • 1.2
  • Market Cap Cr
  • 64,655
  • P/B Ratio
  • Average True Range
  • 23.01
  • EPS
  • 13.34
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -27.63
  • RSI
  • 24.58
  • MFI
  • 9.06

Fortis Healthcare Financials

Fortis Healthcare Technicals

EMA & SMA

Current Price
₹856.40
-4.4 (-0.51%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹926.26
  • 50 Day
  • ₹954.45
  • 100 Day
  • ₹927.86
  • 200 Day
  • ₹848.73

Resistance and Support

867.92 Pivot Speed
  • R3 915.58
  • R2 902.07
  • R1 881.43
  • S1 847.28
  • S2 833.77
  • S3 813.13

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Fortis Healthcare Limited, an IHH Healthcare Berhad Company, is a leading healthcare provider in India with 28 facilities, 4,500+ operational beds, and 400+ diagnostics centers. It offers comprehensive healthcare services across India, UAE, Nepal, and Sri Lanka.

Fortis Healthcare (Nse) has an operating revenue of Rs. 8,433.62 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 13% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 8% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at D- which indicates heavy supply, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Fortis Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-11 Quarterly Results
2025-08-06 Quarterly Results & Others Inter-alia, to consider 1. Alteration of rights of debenture holders/ matters affecting the rights & interests of debenture holders of the existing 1,55,000 listed each face value of INR 1,00,000/-... per share(10%)Final Dividend
2025-05-20 Audited Results & Final Dividend
2025-02-07 Quarterly Results
2024-11-08 Quarterly Results
Date Purpose Remarks
2025-07-25 FINAL Rs.1.00 per share(10%)Final Dividend
2024-07-24 FINAL Rs.1.00 per share(10%)Final Dividend
2023-07-20 FINAL Rs.1.00 per share(10%)Final Dividend
View Fortis Healthcare Dividend History Arrow

Fortis Healthcare F&O

Fortis Healthcare Shareholding Pattern

31.17%
24.92%
2.7%
27.9%
1.22%
10.14%
1.95%

About Fortis Healthcare

Fortis Healthcare Ltd. is a leading global healthcare provider headquartered in India, specializing in providing a range of healthcare services including hospitals, diagnostics, and specialized care. Established in 2001, the company has a strong market presence in the healthcare sector.

The company FHL was founded in February 1996. In 2001, the company opened its first medical facility in Mohali, Punjab. It is one among India's top providers of integrated healthcare services. The company's healthcare verticals are mostly made up of diagnostic centers, hospitals, and specialist daycare centers. The organization currently provides healthcare delivery services through 36 healthcare facilities with about 4,000 operating beds spread across India, Nepal, Dubai, and Sri Lanka. 

The company uses SRL Limited, a subsidiary it owns 57% of, to manage its diagnostics division. It's one of the biggest chains of private diagnostics. With an established strength of 415 laboratories, 8,200 direct clients, and 1,400 Collection Centers, it is present in more than 600 cities and towns.

View More
  • NSE Symbol
  • FORTIS
  • BSE Symbol
  • 532843
  • Managing Director & CEO
  • Dr. Ashutosh Raghuvanshi
  • ISIN
  • INE061F01013

Similar Stocks to Fortis Healthcare

Fortis Healthcare FAQs

Fortis Healthcare share price is ₹856 As on 09 December, 2025 | 10:29

The Market Cap of Fortis Healthcare is ₹64654.6 Cr As on 09 December, 2025 | 10:29

The P/E ratio of Fortis Healthcare is 63.8 As on 09 December, 2025 | 10:29

The PB ratio of Fortis Healthcare is 8.2 As on 09 December, 2025 | 10:29

Consider the company's performance in the healthcare sector and its financial stability before investing.

Key metrics include patient volume, revenue growth, and profit margins.
 

Open a Demat account with 5paisa Capital and post doing KYC and active account search for the Fortis Healthcare, you can then put order as you prefer.
 

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23